These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3949507)

  • 41. Acceleration of repigmentation in vitiligo by topical minoxidil in patients on photochemotherapy.
    Srinivas CR; Shenoi SD; Balachandran C
    Int J Dermatol; 1990 Mar; 29(2):154-5. PubMed ID: 2323875
    [No Abstract]   [Full Text] [Related]  

  • 42. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
    Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How we treat vitiligo.
    Kenney JA; Grimes PE
    Cutis; 1983 Oct; 32(4):347-8. PubMed ID: 6627994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PUVA treatment of vitiligo: a retrospective study of Turkish patients.
    Sahin S; Hindioğlu U; Karaduman A
    Int J Dermatol; 1999 Jul; 38(7):542-5. PubMed ID: 10440288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rational approach to the treatment of vitiligo and other hypomelanoses.
    Hercogová J; Buggiani G; Prignano F; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Retrospective analysis of the results of treatment of acquired albinism treated at the Dermatological Clinic, Medical Academy, in Lublin 1976-1985].
    Kucharska D; Chodorowska G; Urban J
    Ann Univ Mariae Curie Sklodowska Med; 1986; 41():133-7. PubMed ID: 3154048
    [No Abstract]   [Full Text] [Related]  

  • 49. [Vitiligo: 3 treatments compared].
    Veronesi S; Melino M; Andriani GC; Bardazzi F; Ghetti P; Zauli D
    G Ital Dermatol Venereol; 1987 Mar; 122(3):135-7. PubMed ID: 3596649
    [No Abstract]   [Full Text] [Related]  

  • 50. Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet A.
    Abdel-Naser MB; El-Khateeb EA; Sallam TH; Habib MA
    Clin Exp Dermatol; 2006 Jul; 31(4):571-5. PubMed ID: 16716165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effectiveness of topical calcineurin inhibitors compared with topical corticosteroids in the treatment of vitiligo: A systematic review and meta-analysis.
    Chang HC; Hsu YP; Huang YC
    J Am Acad Dermatol; 2020 Jan; 82(1):243-245. PubMed ID: 31408687
    [No Abstract]   [Full Text] [Related]  

  • 52. [The clinical picture and therapy of vitiligo].
    Thiele B
    Dtsch Med Wochenschr; 1991 Jun; 116(26):1025-9. PubMed ID: 2060470
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of pimecrolimus with clobetasol propionate in the treatment of localized vitiligo.
    Bagherani N
    Dermatol Ther; 2016 Jul; 29(4):288. PubMed ID: 26445411
    [No Abstract]   [Full Text] [Related]  

  • 54. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response of vitiligo to PUVA therapy in Saudi patients.
    Tallab T; Joharji H; Bahamdan K; Karkashan E; Mourad M; Ibrahim K
    Int J Dermatol; 2005 Jul; 44(7):556-8. PubMed ID: 15985023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
    Rojas-Urdaneta JE; Poleo-Romero AG
    Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psoralens in photochemotherapy of skin diseases.
    Pathak MA; Parrish JA; Fitzpatrick TB
    Farmaco Sci; 1981 Jul; 36(7):479-91. PubMed ID: 7274436
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS; Kaur I; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.